1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Volpon, L. Lamthanh, H. Barbier, J. Gilles, N. Molgo, J. Menez, A. Lancelin, J.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C5 H9 N O3 131.130 n 4-HYDROXYPROLINE HYDROXYPROLINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 279 21356 21366 10.1074/jbc.M309594200 14976206 NMR Solution Structures of delta-Conotoxin EVIA from Conus ermineus That Selectively Acts on Vertebrate Neuronal Na+ Channels. 2004 To be Published 0353 Conotoxin EVIA, a Novel Peptide from Conus ermineus Venom that Preferentially Acts on Neuronal Voltage-dependent Sodium Channels 10.2210/pdb1g1p/pdb pdb_00001g1p 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 THIS STRUCTURE IS IN EQUILIBRIUM WITH THE LEU12-PRO13 CIS ISOMER (1G1Z). 3294.909 CONOTOXIN EVIA 1 syn polymer no yes DDCIK(HYP)YGFCSLPILKNGLCCSGACVGVCADL(NH2) DDCIKPYGFCSLPILKNGLCCSGACVGVCADLX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2000-11-01 1 1 2008-04-01 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_dist_value _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id 1G1Z represents the conotoxin EVIA with the Leu12-Pro13 cis peptide bond. RCSB Y RCSB 2000-10-13 REL REL The solid phase synthesis of conotoxin EVIA was carried out using the F-moc chemistry. The sequence of the peptide is naturally found in Conus ermineus (Atlantic fish-hunting cone). sample This structure was determined using standard 2D homonuclear techniques structures with the least restraint violations,structures with the lowest energy 30 18 NOESY DQF-COSY 0.01 3.0 ambient 283 K the structures are based on a total of 256 restraints, 210 are NOE-derived distance constraints, 24 dihedral angle restraints and 22 distance restraints from hydrogen bonds. hybrid distance geometry dynamical simulated annealing with the allhdg force field and simulated annealing with the CHARMM22 force field 13 closest to the average 2mM conotoxin EVIA; 90% H2O, 10% D2O 90% H2O/10% D2O Bruker collection XwinNMR 2.6 Delsuc data analysis Gifa 4.22 Brunger refinement X-PLOR 3.851 Brooks refinement CHARMM 22 500 Bruker DRX ASP 1 n 1 ASP 1 A ASP 2 n 2 ASP 2 A CYS 3 n 3 CYS 3 A ILE 4 n 4 ILE 4 A LYS 5 n 5 LYS 5 A HYP 6 n 6 HYP 6 A TYR 7 n 7 TYR 7 A GLY 8 n 8 GLY 8 A PHE 9 n 9 PHE 9 A CYS 10 n 10 CYS 10 A SER 11 n 11 SER 11 A LEU 12 n 12 LEU 12 A PRO 13 n 13 PRO 13 A ILE 14 n 14 ILE 14 A LEU 15 n 15 LEU 15 A LYS 16 n 16 LYS 16 A ASN 17 n 17 ASN 17 A GLY 18 n 18 GLY 18 A LEU 19 n 19 LEU 19 A CYS 20 n 20 CYS 20 A CYS 21 n 21 CYS 21 A SER 22 n 22 SER 22 A GLY 23 n 23 GLY 23 A ALA 24 n 24 ALA 24 A CYS 25 n 25 CYS 25 A VAL 26 n 26 VAL 26 A GLY 27 n 27 GLY 27 A VAL 28 n 28 VAL 28 A CYS 29 n 29 CYS 29 A ALA 30 n 30 ALA 30 A ASP 31 n 31 ASP 31 A LEU 32 n 32 LEU 32 A NH2 33 n 33 NH2 33 A author_defined_assembly 1 monomeric A HYP 6 4-HYDROXYPROLINE A HYP 6 PRO 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A HG O SER ALA 22 30 1.60 3 A A HG O SER ALA 22 30 1.59 4 A A HG O SER ALA 22 30 1.60 10 A A HG O SER ALA 22 30 1.60 11 A A HG O SER ALA 22 30 1.57 12 A A HG O SER ALA 22 30 1.60 13 A A HG O SER ALA 22 30 1.58 15 A A HG O SER LYS 11 16 1.57 17 A A HG OD1 SER ASN 11 17 1.57 4 A A GLY ALA 23 24 -149.46 5 A A PRO ILE 13 14 -149.45 13 A A PRO ILE 13 14 -147.54 11 A TYR 7 0.070 SIDE CHAIN 1 -16.71 2.70 111.00 94.29 A A A N CA C ILE ILE ILE 14 14 14 N 1 -16.73 2.70 111.00 94.27 A A A N CA C LEU LEU LEU 32 32 32 N 2 -16.39 2.70 111.00 94.61 A A A N CA C LEU LEU LEU 32 32 32 N 3 -17.04 2.70 111.00 93.96 A A A N CA C LEU LEU LEU 32 32 32 N 4 -16.88 2.70 111.00 94.12 A A A N CA C LYS LYS LYS 16 16 16 N 4 -17.82 2.50 113.10 95.28 A A A N CA C GLY GLY GLY 18 18 18 N 7 -17.62 2.70 111.00 93.38 A A A N CA C SER SER SER 11 11 11 N 7 -15.82 2.50 113.10 97.28 A A A N CA C GLY GLY GLY 18 18 18 N 8 -16.87 2.50 113.10 96.23 A A A N CA C GLY GLY GLY 18 18 18 N 9 -16.52 2.70 111.00 94.48 A A A N CA C LEU LEU LEU 32 32 32 N 10 -16.74 2.50 113.10 96.36 A A A N CA C GLY GLY GLY 18 18 18 N 11 -17.06 2.70 111.00 93.94 A A A N CA C LEU LEU LEU 32 32 32 N 13 -16.64 2.70 111.00 94.36 A A A N CA C LEU LEU LEU 32 32 32 N 14 -16.57 2.70 111.00 94.43 A A A N CA C LEU LEU LEU 12 12 12 N 14 -16.99 2.50 113.10 96.11 A A A N CA C GLY GLY GLY 18 18 18 N 14 -16.50 2.70 111.00 94.50 A A A N CA C LEU LEU LEU 32 32 32 N 15 -17.27 2.50 113.10 95.83 A A A N CA C GLY GLY GLY 18 18 18 N 15 -18.33 2.70 111.00 92.67 A A A N CA C VAL VAL VAL 26 26 26 N 15 -16.34 2.70 111.00 94.66 A A A N CA C LEU LEU LEU 32 32 32 N 17 -17.16 2.70 111.00 93.84 A A A N CA C LEU LEU LEU 19 19 19 N 17 -18.31 2.70 111.00 92.69 A A A N CA C VAL VAL VAL 26 26 26 N 17 -16.59 2.70 111.00 94.41 A A A N CA C LEU LEU LEU 32 32 32 N 18 9.63 1.50 110.50 120.13 A A A N CA CB SER SER SER 11 11 11 N 18 -17.60 2.70 111.00 93.40 A A A N CA C SER SER SER 11 11 11 N 18 -18.21 2.50 113.10 94.89 A A A N CA C GLY GLY GLY 18 18 18 N 18 -16.72 2.70 111.00 94.28 A A A N CA C LEU LEU LEU 32 32 32 N 1 A ASP 2 178.85 -170.98 1 A ALA 30 -121.48 -156.80 2 A SER 11 -121.32 -80.11 2 A LEU 15 52.63 -121.37 2 A LEU 19 -118.66 72.65 2 A VAL 26 -133.24 -138.60 2 A ALA 30 -151.50 -146.10 3 A ASP 2 -88.65 -147.78 3 A SER 11 154.89 -89.06 3 A LEU 15 -109.63 59.54 3 A LYS 16 73.68 -58.24 3 A VAL 26 -141.77 41.47 3 A ALA 30 -145.89 -140.70 4 A CYS 3 -118.75 -169.75 4 A SER 11 172.29 -158.76 4 A LEU 19 -129.30 -165.14 4 A ALA 30 -144.26 -146.75 5 A ILE 14 -72.52 29.97 5 A VAL 26 -146.47 48.29 5 A ALA 30 -133.78 -142.77 6 A ASP 2 -109.27 -113.38 6 A LYS 16 -59.75 106.36 6 A VAL 26 -149.16 51.50 7 A SER 11 168.79 -145.98 7 A PRO 13 -140.76 28.96 7 A ILE 14 -126.03 -55.73 7 A LEU 15 -124.19 -162.59 7 A LYS 16 -95.46 34.62 7 A VAL 26 -142.67 39.03 7 A ALA 30 -148.35 -152.93 7 A ASP 31 -175.10 -171.87 8 A ASP 2 -103.94 -114.77 8 A ILE 14 72.85 -58.86 8 A VAL 26 -142.46 42.91 8 A ALA 30 -129.55 -164.44 9 A SER 11 -168.83 -169.90 9 A ILE 14 -142.75 -90.16 9 A VAL 26 -127.68 -125.81 9 A ALA 30 -128.28 -165.46 10 A ASP 2 -90.60 -133.53 10 A SER 11 -169.48 -168.12 10 A ILE 14 -151.06 -50.67 10 A LEU 15 -125.58 -163.10 10 A VAL 26 -152.44 62.80 10 A ALA 30 -125.55 -147.56 11 A CYS 10 -117.17 -118.35 11 A SER 11 -154.13 -136.85 11 A LEU 15 -108.95 -72.08 11 A LYS 16 -124.15 -96.95 11 A ASN 17 177.66 -165.20 11 A VAL 26 -151.21 65.45 11 A ALA 30 -139.45 -152.36 12 A ASP 2 -102.69 -106.17 12 A SER 11 -174.49 -156.55 12 A ILE 14 -164.60 -51.42 12 A LEU 15 -115.00 -158.28 12 A ASN 17 -176.26 -171.97 12 A VAL 26 -158.19 55.98 12 A ALA 30 -145.62 -149.39 13 A CYS 10 -106.82 78.98 13 A LEU 15 -158.69 -54.91 13 A VAL 26 -149.60 43.57 13 A ALA 30 -148.62 -146.62 14 A ASP 2 -97.65 -68.91 14 A SER 11 167.57 -174.48 14 A VAL 26 -146.88 44.78 15 A PRO 13 -73.65 41.25 15 A LEU 15 -127.38 -137.38 15 A VAL 26 -160.69 -140.55 15 A ALA 30 -141.22 -154.93 16 A CYS 3 -171.32 -175.72 16 A SER 11 -175.02 -158.63 16 A ILE 14 171.09 -39.75 16 A LYS 16 -95.97 54.99 16 A VAL 26 -150.61 56.54 16 A ALA 30 -142.79 -141.63 17 A ASP 2 67.71 -148.49 17 A SER 11 -87.16 -105.82 17 A ILE 14 -140.21 -68.48 17 A VAL 26 -160.31 -142.92 17 A ALA 30 -144.23 -155.17 18 A ASP 2 -113.82 -74.67 18 A SER 11 141.20 -139.30 18 A ILE 14 75.03 -64.90 18 A VAL 26 -135.19 -129.87 18 A ALA 30 -152.11 -151.23 NMR Solution Structures of delta-Conotoxin EVIA from Conus ermineus that Selectively Acts on Vertebrate Neuronal Na+ Channels 1 N N disulf 2.027 A CYS 3 A SG CYS 3 1_555 A CYS 21 A SG CYS 21 1_555 disulf 2.019 A CYS 10 A SG CYS 10 1_555 A CYS 25 A SG CYS 25 1_555 disulf 2.019 A CYS 20 A SG CYS 20 1_555 A CYS 29 A SG CYS 29 1_555 covale 1.328 both A LYS 5 A C LYS 5 1_555 A HYP 6 A N HYP 6 1_555 covale 1.354 both A HYP 6 A C HYP 6 1_555 A TYR 7 A N TYR 7 1_555 covale 1.356 both A LEU 32 A C LEU 32 1_555 A NH2 33 A N NH2 33 1_555 TOXIN three disulfide linkages, cis/trans isomerism of Leu12-Pro13 peptide bond, hydroxyproline, TOXIN CXD6A_CONER UNP 1 1 P60513 1 32 1G1P 1 32 P60513 A 1 1 32 BINDING SITE FOR RESIDUE NH2 A 33 A NH2 33 Software 1 A LEU 32 A LEU 32 1 1_555 1 P 1